{"article": [{"url": "https://www.marketwatch.com/story/bausch-health-shares-jump-6-premarket-after-company-offers-upbeat-revenue-guidance-2020-10-08", "published": 1602141440.0, "headline": "Bausch Health shares jump 6% premarket after company offers upbeat revenue guidance", "body": "Bausch Health Cos. Inc. shares BHC, -3.10% soared 6% in premarket trade Thursday, after the company said it expects third-quarter revenue to exceed $2.1 billion, ahead of the FactSet consensus of $1.99 billion. \"Additionally, based on the pace of recovery of its various businesses observed in the third quarter of 2020 and assuming its businesses continue to rebound from the impact of the COVID-19 pandemic, Bausch Health currently expects its full-year 2020 revenue and Adjusted EBITDA (non-GAAP) to be around the midpoint of its current guidance ranges of $7.80 -- $8.00 billion for revenue and $3.15 - $3.30 billion for 2020 Adjusted EBITDA (non-GAAP),\" the company said in a statement. Bausch, the former Valeant, will report its third-quarter earnings on Nov. 3. Shares have fallen 46% in the year to date, while the S&P 500 SPX, +0.87% has gained 5.8%."}]}